Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Moyamoya disease in a patient with neuromyelitis optica.
Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial.
Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation.
Comprehensive analysis of human endogenous retrovirus group HERV-W locus transcription in multiple sclerosis brain lesions by high throughput amplicon sequencing.
Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells.
Multiple sclerosis for nurse practitioners.
Predictors of recurrence following an initial episode of transverse myelitis.
Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases.
Human interferon regulatory factor 5 homologous epitopes of Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis induce a specific humoral and cellular immune response in multiple sclerosis patients.
Axonal degeneration in multiple sclerosis: defining therapeutic targets by identifying the causes of pathology.
Staying on the job: The relationship between work performance and cognition in individuals diagnosed with multiple sclerosis.
Dextromethorphan/Quinidine for the treatment of pseudobulbar affect.
Sphingosine-1-phosphate Receptor 1 (S1P1 ) Signaling in T cells: Trafficking and Beyond.
Oral fingolimod to treat multiple sclerosis: see your cardiologist first.
CCR5 knockout suppresses experimental autoimmune encephalomyelitis in C57BL/6 mice.
Validity of Oxygen Uptake Efficiency Slope in patients with multiple sclerosis.
Interferon-beta-induced pulmonary sarcoidosis in a 30-year-old woman treated for multiple sclerosis: a case report.
Multiple sclerosis relapse phenotype is an important, neglected determinant of disease-outcome: Commentary.
Non pharmacological interventions for spasticity in multiple sclerosis.
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE.
A case of simultaneous neuromyelitis optica spectrum disorder and subacute combined degeneration.
Application of q-Space Diffusion MRI for the Visualization of White Matter.
The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of γ-Herpesvirus Infected B Cells in the Marmoset EAE Model.
Falls in people with multiple sclerosis compared with falls in healthy controls.
Plasmablasts as Migratory IgG-Producing Cells in the Pathogenesis of Neuromyelitis Optica.
Pages
« first
‹ previous
…
516
517
518
519
520
521
522
523
524
…
next ›
last »